Category Uncategorized


Radiation Oncology Podcast Series: Insights in Head and Neck Cancer: Treatment Options and Associated Toxicities.

Dr. Adam Dicker Chairman of the Department of Radiation Oncology conducts the latest Radiation Oncology podcast with Otolaryngologist Dr.  Adam Luginbuhl Key Discussions: Interest in Head & Neck Cancer His passion to reduce the toxicities of treatment His current collaborative research efforts How we resemble each other! Check out the Podcast (Click Here)


Radiation Oncology Podcast Series: In Chinese-How to be successful in US – China academic collaborations

Dr. Adam Dicker Interviews – Dr. Shi, Dr. Yu, Dr. Dicker and Dr. Ma (answers in Mandarin) (Listen Here) Our round table discussion included: How to be successful in US – China academic collaborations Entrepreneurship in US vs China A whole lot More! Dr, Shi, MD, PhD Yan Yu, PhD, MBA Xin-Ling Ma, MD, PhD


Dr. Adam Dicker featured in Oncology Times: Removing the Gag on Safety Error Reporting

Radiology has been something like a trapeze artist performing without a net. The perfected feats can be spectacular to behold, but a slip of a grip and the result can be tragic. Adam Dicker, MD, PhD, Professor and Chair of the Department of Radiation Oncology at Sidney Kimmel Medical College, and Sidney Kimmel Cancer Center …


Jefferson’s Buddy Program Gives Patients with Cancer Somebody to Lean On

                                                                                                                                                                                                                                                                                                                        Joe Lavalle, a Sidney Kimmel Cancer Center at Jefferson Buddy Program volunteer. The Sidney Kimmel Cancer Center at Jefferson Buddy Program matches patients diagnosed with prostate, breast and other types of cancer with survivors who have experienced the same or similar diagnoses, treatments and uncertainties. Their “survivor buddies” are cancer survivors ahead of them …


Dr. Leonard Gomella: “Blue light” cystoscopy for detection and treatment of non-muscle invasive bladder cancer

Dr. Leonard Gomella, MD In patients with non-muscle invasive bladder cancer, fluorescence cystoscopy can improve the detection and ablation of bladder tumors. In this paper we describe the technique and practical aspects of hexaminolevulinate (HAL) fluorescence cystoscopy, also known as “blue light cystoscopy”. Check out Dr. Gomella’s  Blue Light Video (Click Here)


Jefferson Harnessing “Big Data” to Broaden Cancer Research

With the help of internal and external collaborations, researchers in our Computational Medicine Center (CMC) at the Sidney Kimmel Medical College here at TJU are characterizing and analyzing the molecular drivers of several cancers, which may lead to more powerful diagnostics and personalized treatments that better target cancer’s root causes. The use of precision medicine …


Researchers Find Pathway that Could Make Abandoned Pancreatic Cancer Drug Effective Against the Disease

Our scientists have found that blocking one molecular pathway could make pancreatic cancer susceptible to formerly ineffective therapies. “While there’s more work to be done to confirm the results in pre-clinical models and then humans, we are encouraged by these preliminary results,” said Jonathan Brody, PhD, a researcher at our Sidney Kimmel Cancer Center and Director …


Dr. Gomella featured in Targeted Oncology

Experts Discuss Treatment Sequencing Strategies in CRPC As the treatment landscape for patients with metastatic castration-resistant prostate cancer (CRPC) continues to evolve, optimal strategies are becoming more apparent on how to best sequence the multitude of novel therapies that have been approved in the past decade. To gain insight into current best practices and strategies …


Sky Community Partners 2nd Annual Point Breeze 5K Run & Health Fair

On Saturday, April 16, 2016 Jefferson and the Sidney Kimmel Cancer Center was  pleased to partner with Sky Community Partners on their 2nd Annual Point Breeze 5k Run/Walk & Health Fair! The 5k Run/Walk  raised funds to promote and support pancreatic cancer awareness and early detection and to encourage healthy lifestyles, specifically in underserved communities. …


Dr. Dicker featured in Oncology Times: The Role of Genomics in Prostate Cancer Care

Fertile Genomic Ground Leads to Growth of Technology, Knowledge Laberta, Valerie As medical oncology harvests the advantages of this fertile genomic age, so do the associated therapies that benefit cancer patients. Radiation oncology has sprouted some new opportunities for improved patient care and outcomes, now ripening with the help of technology and research. Adam Dicker, …


Exceptional Care at the SKCC from Dr’s. Bar-Ad and Axelrod

Check out a patient story in Philadelphia Row Home Magazine. He discusses his exceptional care in the hands of the SKCC and includes the names of a number of Jefferson docs. Here’s a link to the story: (Page 17 – Fight Like Hell)


Reimagining Patient Engagement: Jefferson-Designed Application Helps Patients Make More-Informed Shared Medical Decisions

Making decisions about healthcare options can seem overwhelming to patients and their families, and, in many cases, patients are asked to make decisions even though they have a limited understanding of their options. The Decision Counseling Program (DCP) is an online software application that enables patients to make well-informed healthcare decisions together with their treating …


Grand Rounds Shared Resources Special Event

Come and see what the Sidney Kimmel Cancer Center Shared Resources can do for you! Informatics, Jack London, PhD CTC, Hushan Yang, PhD X-Ray Crystallography, Michael Root, PhD April 20th, 2016 at 12pm Mandeville Auditorium, BLSB 101 Lunch will be served!


Brittany Simone awarded AACR Travel Grant from Taconic

  Taconic Celebrates Researchers Awarded AACR Travel Grant The AACR Annual Meeting is the premier meeting for cancer research. The 2016 meeting will be held April 16-20 in New Orleans, Louisiana, USA. The program includes sessions on precision checkpoint immunotherapy, CRISPR in drug discovery, CAR T cells, immunotherapy combination treatments, and much more. Taconic has provided four …


High-dose radiation may be no better for low-risk prostate cancer by Dr. Robert Den

“In the field of radiation oncology, we often assume that the highest dose that the body can tolerate will be most effective at killing cancer,” said senior study author Dr. Robert Den, a researcher at Thomas Jefferson University’s Sidney Kimmel Cancer Center in Philadelphia. “Our results argue that this may not be the case, at …


Dr. Gomella on Current Perspectives on Prostate Cancer Screening

Leonard Gomella, MD, physician, professor, and chair of the Department of Urology at Thomas Jefferson University and director of the Sidney Kimmel Cancer Center Network, discusses the current perspectives on screening for prostate cancer. Controversy remains on screening for prostate cancer, as the United States Preventative Services Task Force advises that men should not be …


Radiation Oncology Podcast: Residency Program

Check out the latest Radiation Oncology podcast version 4 focusing on the Radiation Oncology residency program featuring :       Adam Dicker, MD, PhD Michael Hardin, MS, MPR2 Amy S. Harrison, MS Virginia Lockamy, PhD                     Emily Kremmel, MMP, MPR2 James Keller, PhD   …


Dr. Adam Dicker featured in OncologyNurseAdvisor

Radiotherapy/Histone Deacetylase Inhibitor Combination Safe, Effective in High-grade Gliomas Adding panobinostat to radiotherapy appears safe, tolerable, and has preliminary efficacy for treating recurrent high-grade gliomas, according to a phase 1 clinical trial published in the Journal of Neuro-Oncology. The trial combined fractionated stereotactic re-irradiation therapy (FSRT) with panobinostat.1 “We saw synergy between radiotherapy and the …


Conserved gene can act to inhibit lung cancer development, study finds featuring SKCC Researcher Dr. Bo Lu

Scientists believe that “conserved” genes — those found in life forms that range from bacteria to plants, insects and humans — perform vital biological functions across species. And limited research on one of those genes, Nitrilase 1 (Nit1), suggested it acts to inhibit cancer development. But researchers at Sidney Kimmel Cancer Center have found Nit1 …


For prostate cancer, more radiation may not improve survival featuring Dr. Robert Den

Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) New technology has enabled doctors to administer higher doses of radiation to prostate cancer patients with fewer side effects. However, a new study shows that escalating the dose may not actually help a patient in the long term, at least not patients with …

Page 1 of 7